Steve Beuchaw

Stock Analyst at Morgan Stanley

(2.39)
# 2,613
Out of 5,044 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return

Stocks Rated by Steve Beuchaw

Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $52$49
Current: $47.95
Upside: +3.11%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $145.85
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711$770
Current: $133.14
Upside: +478.34%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $38.72
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $63.21
Upside: +7.58%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $13.07
Upside: +404.97%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320$288
Current: $97.80
Upside: +194.48%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254$260
Current: $557.63
Upside: -53.37%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204$211
Current: $345.95
Upside: -39.01%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51$54
Current: $8.13
Upside: +564.21%
Maintains: Overweight
Price Target: $21$41
Current: $189.57
Upside: -78.37%
Initiates: Equal-Weight
Price Target: $335
Current: $330.42
Upside: +1.39%
Initiates: Equal-Weight
Price Target: $335
Current: $338.00
Upside: -0.89%